| 4HGT | A:; B: | CRYSTAL STRUCTURE OF CK1D WITH COMPOUND 13 |
| 4HNF | A:; B: | CRYSTAL STRUCTURE OF CK1D IN COMPLEX WITH PF4800567 |
| 4KB8 | A:; B:; C:; D: | CK1D IN COMPLEX WITH 1-{4-[3-(4-FLUOROPHENYL)-1-METHYL-1H-PYRAZOL-4-YL]PYRIDIN-2-YL}-N-METHYLMETHANAMINE LIGAND |
| 4KBA | A:; C:; D:; B: | CK1D IN COMPLEX WITH 9-[3-(4-FLUOROPHENYL)-1-METHYL-1H-PYRAZOL-4-YL]-2,3,4,5-TETRAHYDROPYRIDO[2,3-F][1,4]OXAZEPINE INHIBITOR |
| 4KBC | A:; B: | CK1D IN COMPLEX WITH {4-[3-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL]PYRIDIN-2-YL}METHANOL INHIBITOR |
| 4KBK | A:; B:; C:; D: | CK1D IN COMPLEX WITH (3S)-3-{4-[3-(4-FLUOROPHENYL)-1-METHYL-1H-PYRAZOL-4-YL]PYRIDIN-2-YL}MORPHOLINE INHIBITOR |
)
)